UWMDI Co-Director, Stephanie Page, talked to KUOW
Dr. Stephanie Page, professor and head (Metabolism, Endocrinology and Nutrition) talked to KUOW in “Are we nearing the end of the long road to hormonal birth control for men?”
Read MoreDr. Stephanie Page, professor and head (Metabolism, Endocrinology and Nutrition) talked to KUOW in “Are we nearing the end of the long road to hormonal birth control for men?”
Read MoreDr. Steven Kahn, professor (Metabolism, Endocrinology and Nutrition) has been appointed incoming editor-in-chief of Diabetes Care, the highest-ranked journal devoted to original diabetes-related research.
Read MoreDr. Stephanie Page, MD, PhD, has an editorial published in the New York Times, titled, “Is Society Ready for Male Birth Control?” Read Article Here
Read MoreDrs. Laura Crisa, associate professor (Metabolism, Endocrinology & Nutrition) and Farid Moussavi-Harami, assistant professor (Cardiology) have received prestigious awards from the John H. Tietze Foundation Trust that will help fuel
Read MoreThe results of the vote for the UWMDI SLU Trainee of the Year are in! In selecting the trainee, you were asked to consider the quality of presentations (organization, clarity,
Read MoreThe laboratory of Michael Schwartz, Gregory Morton and Jarrad Scarlett in the Department of Medicine, at the University of Washington is looking for a highly, motivated postdoctoral research fellow to
Read MoreDr. Karin Bornfeldt, professor (Metabolism, Endocrinology and Nutrition) is senior author of “Diabetes Suppresses Glucose Uptake and Glycolysis in Macrophages” in Circulation Research. DOM co-authors are Masami Shimizu-Albergine, Shelley Barnhart,
Read MoreDrs. Farah Khan, clinical assistant professor, and Irl Hirsch, professor, wrote “Diabetes and the WHO Model List of Essential Medicines” in The Lancet Diabetes & Endocrinology.
Read MoreDr. Irl Hirsch, professor, is quoted in “A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.” in the New York Times.
Read MoreDr. Irl Hirsch, professor is quoted in “Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive” in Fortune.
Read More